Medpace Holdings, Inc.
MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and develā¦ read more
Healthcare
Diagnostics & Research
9 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$590.09
Price-0.21%
-$1.23
1Y
Price
Market Cap
$16.622b
Large
Price/Earnings 3y Avg5y Avg
41.2x
Premium
Premium
Financials Overview
Key metrics over the past few years+22.7%
EBITDA Margin+16.8%
Net Profit Margin+39.8%
Free Cash Flow MarginRevenue
$2.358b
+11.8%
1y CAGR+17.6%
3y CAGR+20.2%
5y CAGREarnings
$433.008m
+7.1%
1y CAGR+21.8%
3y CAGR+25.1%
5y CAGREPS
$14.31
+13.3%
1y CAGR+25.8%
3y CAGR+32.2%
5y CAGRBook Value
$293.641m
$1.753b
Assets$1.459b
Liabilities$143.973m
DebtDebt to Assets
8.2%
0.3x
Debt to EBITDAFree Cash Flow
$703.594m
+23.0%
1y CAGR+26.7%
3y CAGR+32.4%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company